R&D Advancement: Road to New Medicines

Innovation—it is what everyone likes to talk about, but what does it really mean for millions of patients battling disease? Simply put, medical innovation can help patients live longer, healthier and more productive lives.

As one of the most research-intensive and science-driven industries in the U.S., the biopharmaceutical industry is committed to the research and development (R&D) of new treatments and cures for patients, including those who have serious unmet medical needs.  With more than 7,000 innovative drugs in development worldwide by biopharmaceutical companies and over $500 billion invested in R&D since 2000, hope is certainly on the horizon.

Patients are not the only ones who benefit from new drug development.  When new medicines keep patients healthier, the economy gets a boost from a healthier workforce, the cost of healthcare can go down and access improves.  Perhaps above all else, medical advances give patients one essential ingredient for survival: hope.

The biopharmaceutical sector is the most research-intensive industry in the country, investing more than 10 times the amount of R&D per employee than manufacturing industries on average. With our rapidly increasing understanding of disease at the molecular level, science holds more promise for progress against many diseases today than at any time in history. The biopharmaceutical pipeline is demonstrating that promise.

The worldwide market for research and advancement is relied upon to develop from almost $86.5 billion in 2015 to $124.3 billion in 2020 at a yearly development rate of 7.5% from 2015-2020.

  • New Medicines: Changing Lives and Managing Health Care Costs
  • Research – Identifying a New Approach to Treat a Disease or Condition
  • The Biopharmaceutical Research Ecosystem Drives Innovation

Related Conference of R&D Advancement: Road to New Medicines

October 25-26, 2019

14th International Conference on Biopharma and Biotherapeutics

| Copenhagen, Denmark
October 23-24, 2019 | Copenhagen, Denmark

12th Pharma Congress

September 11-12, 2019

2nd Annual Pharmaceutical Biotechnology Congress

Singapore
November 11-12, 2019

20th Annual Pharma Middle East Congress

Renaissance Polat Istanbul Hotel | Istanbul, Turkey
November 18-19, 2019

European Congress on Nanomedicine and Pharmaceutical Nanotechnology

Prague, Czech Republic
November 18-19, 2019

European Conference on Pharmacovigilance & Drug Safety

Prague, Czech Republic
December 02-03, 2019

15th Annual Congress on Pharmacology and Toxicology

Paris, France
February 12-13, 2020

14th Global Pharmacovigilance and Clinical Trials Summit

Sydney, Australia
February 12-13, 2020

2nd International Conference on Biosimilars & Pharmaceuticals

Auckland, New Zealand
March 25-26, 2020

23rd Asia Pacific Pharma Congress

Singapore
April 01-02, 2020

13th European Biosimilars Congress 2020

London, UK
April 09-10, 2020

World Pharma Expo

Bangkok, Thailand
April 27-28, 2020

5th Pharmaceutical Chemistry Conference

Prague, Czech Republic
April 27-28, 2020

7th European Biopharma Congress

Prague, Czech Republic
May 06-07, 2020

15th Annual Meet on Euro Ethnopharmacology

Prague | Czech Republic
May 18-19, 2020

30th Annual European Pharma Congress

Berlin, Germany
May 27- 28, 2020

14 th World Drug Delivery Summit

| London, UK
August 26-27, 2020

33rdWorld Congress on Pharmacology

Barcelona, Spain
September 10-11, 2020

World Congress on Rare Diseases & Orphan Drugs

| Prague, Czech Republic
September 21-22, 2020

35th World Pharmacology and Toxicology Forum

Tokyo, Japan
October 19-20, 2020

Innovation in Drug Design Techniques and Pharmacology

| Paris, France
December 02-03, 2020

International Conference onBiotechnology and Healthcare

Auckland, Newzealand
December 06-07, 2021

22nd Pharma Middle East Congress

Dubai, UAE

R&D Advancement: Road to New Medicines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in